Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuria Porta

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
BMC Medical Research Methodology|September 19, 2022
Joint models for dynamic prediction in localised prostate cancer: a literature reviewHarry Parr, Emma Hall, Nuria Porta
Drug Discovery Today|December 15, 2016
Molecular similarity considerations in the licensing of orphan drugsPedro Franco, Nuria Porta, John D Holliday, et al.
Journal of Cheminformatics|February 4, 2014
The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislationPedro Franco, Nuria Porta, John D Holliday, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 TrialHarry Parr, Nuria Porta, Alison C Tree, et al.
Cancer Treatment Reviews|June 18, 2023
Clinical trial designs for evaluating and exploiting cancer evolutionAlvaro H Ingles Garces, Nuria Porta, Trevor A Graham, et al.
Medicina Clinica|May 12, 2012
[Prevalence of chronic renal insufficiency in diabetic type 2 diabetes patients based on the estimated glomerular filtration rate and relation with cardiovascular risk]Teresa Mur Martí, Mercè Villaró Gabarrós, Nuria Porta Martínez, et al.
Diagnostic Microbiology and Infectious Disease|January 2, 2013
GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?Laura Muñoz, Raquel Moure, Nuria Porta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2017
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trialsJoanne S Haviland, Mariella Mannino, Clare Griffin, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Oncotarget|August 26, 2021
Hypofractionation: less is more?Neethu Billy Graham Mariam, Yee Pei Song, Nuradh Joseph, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
BMC Medical Research Methodology|September 19, 2022
Joint models for dynamic prediction in localised prostate cancer: a literature reviewHarry Parr, Emma Hall, Nuria Porta
Drug Discovery Today|December 15, 2016
Molecular similarity considerations in the licensing of orphan drugsPedro Franco, Nuria Porta, John D Holliday, et al.
Journal of Cheminformatics|February 4, 2014
The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislationPedro Franco, Nuria Porta, John D Holliday, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2023
A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 TrialHarry Parr, Nuria Porta, Alison C Tree, et al.
Cancer Treatment Reviews|June 18, 2023
Clinical trial designs for evaluating and exploiting cancer evolutionAlvaro H Ingles Garces, Nuria Porta, Trevor A Graham, et al.
Medicina Clinica|May 12, 2012
[Prevalence of chronic renal insufficiency in diabetic type 2 diabetes patients based on the estimated glomerular filtration rate and relation with cardiovascular risk]Teresa Mur Martí, Mercè Villaró Gabarrós, Nuria Porta Martínez, et al.
Diagnostic Microbiology and Infectious Disease|January 2, 2013
GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?Laura Muñoz, Raquel Moure, Nuria Porta, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2017
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trialsJoanne S Haviland, Mariella Mannino, Clare Griffin, et al.
Clinical Genitourinary Cancer|March 8, 2020
Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT TrialEdward Cox, Pedro Saramago, John Kelly, et al.
Oncotarget|August 26, 2021
Hypofractionation: less is more?Neethu Billy Graham Mariam, Yee Pei Song, Nuradh Joseph, et al.
Pageof 6